ZNGA - Hot Stocks: SYNA RAMP jump on earnings; ZGNX ZNGA drop; DRNA tumbles on mixed clinical trial data

Earnings news sparked big moves in individual stocks during Friday's midday trading. Synaptics (NASDAQ:SYNA) and LiveRamp (NYSE:RAMP) both advanced following the release of their quarterly results. Meanwhile, financial figures sent Zogenix (NASDAQ:ZGNX) and Zynga (NASDAQ:ZNGA) reeling. Dicerna Pharmaceuticals (NASDAQ:DRNA) was one of the major movers in intraday action that came without an earnings release. Instead, the stock plunged on mixed clinical trial data. Synaptics (SYNA) reported a quarterly non-GAAP profit that topped analysts' consensus by 9%. Revenue also surpassed expectations, rising 18% from last year to reach $327.8M. Bolstered by the earnings beat, SYNA climbed over 16% in midday action to trade at $169.99. Shares also reached a 52-week high of $173.12 earlier in the day. LiveRamp (RAMP) also posted a double-digit gain in light of its strong earnings report. The company beat on the top and bottom lines, with revenue that climbed nearly 20% to $119M. RAMP rose 20%

For further details see:

Hot Stocks: SYNA, RAMP jump on earnings; ZGNX, ZNGA drop; DRNA tumbles on mixed clinical trial data